Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01792 (long intergenic non-protein coding RNA 1792) is an annotated non-coding RNA gene in the human genome, classified as a lincRNA. LincRNAs are generally characterized by their lack of protein-coding potential and location in intergenic regions. They typically function to regulate gene expression at transcriptional or epigenetic levels, sometimes through enhancer-like activity or recruitment of chromatin-modifying factors. LINC01792 is included in gene expression datasets and may be differentially expressed in cancer, but its molecular and functional characterization, as well as any clinical relevance, remain unclear. No direct evidence links LINC01792 to druggable pathways or established disease mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1792 (LINC01792).